FDA Inspection 904974 — Central Jersey Blood Center
The FDA completed an inspection of Central Jersey Blood Center on Oct 23, 2014 in Howell, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 23, 2014
- Fiscal Year
- 2015
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Howell, NJ (United States)